Studies have shown that SCFAs play a significant role in the treatment of diabetes by influencing the secretion of GLP-1 and PYY, inflammation, etc. (Ejtahed et al., 2016; Morrison and Preston, 2016). This evidence concerns the gene PYY and diabetes mellitus.